麻豆社

As part of our , the 麻豆社was a commissioner on , a report that makes the case for improving maternal health by using research to increasing access to medicines for use in pregnancy.

, a non-profit organisation that collaborates with the global pharmaceutical sector, has developed a of the existing regulations and guidance on the development and monitoring of medicines taken during pregnancy and breastfeeding. This landscape was written to help pharmaceutical companies better understand and comply with these regulatory requirements, with the aim of including more pregnant women as clinical trial participants.